Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Intratympanic Corticosteroids in Sudden Sensorineural Hearing Loss
NCT06968507Phase 4Recruiting
- Sponsor
- Kartal Dr. Lütfi Kırdar City Hospital
- Start
- Dec 2024
- Primary completion
- Sep 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial in sudden sensorineural hearing loss (SSHL) comparing Oral Methylprednisolone with Intratympanic Dexamethasone (2 arms). Primary endpoint: Pure Tone Average at 2 months. Started Dec 2024; status: recruiting.
02
Drugs
methylprednisolonedexamethasone
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT06968507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06968507.